Molecular Testing Solutions

When it comes to coronavirus, we have flexible solutions for your testing needs.

In response to the global outbreak of the novel coronavirus disease (COVID-19), Luminex has developed multiple solutions to enhance our offerings in order to automate and facilitate the detection of SARS-CoV-2.

ARIES® SARS-CoV-2 Assay (RUO)

For more targeted coronavirus testing in moderate-complexity labs, the ARIES® SARS-CoV-2 Assay (RUO) is a sample-to-answer test that detects SARS-CoV-2 in nasopharyngeal swabs.

The ARIES® SARS-CoV-2 Assay offers:

  • Precise Results: A moderate-complexity, sample-to-answer test that enables targeted SARS-CoV-2 detection.
  • Fast Turnaround Time: Minimal hands-on time and an automated workflow deliver results in about 2 hours.
  • Robust Detection: Exonuclease-sensitive probes for the ORF1ab and N viral genes provide superior specificity.

Additionally, Luminex has LDT tools1 that can be used with the latest published primer sequences to detect SARS-CoV-2, enabling users to develop their own LDTs on the ARIES® sample-to-answer system. Using this approach, labs have already validated their own ARIES®-based, multi-target tests.

A targeted SARS-CoV-2 LDT testing strategy using the ARIES® System offers:

  • Lab-specific testing, including the ability to develop a targeted test for SARS-CoV-2 detection.
  • Customized workflows, allowing users to develop, validate, and automate assays under EU regulations.

Get a behind-the-scenes look at COVID-19 testing at the Carl-Thiem-Klinikum (CTK) Hospital in Cottbus, Germany using our ARIES® sample-to-answer system. Read more here.

SARS-COV-2 White Paper

Watch this video to see how to run the ARIES® SARS-CoV-2 Assay:

Video Thumbnail
ARIES® SARS-CoV-2 Assay Workflow (RUO)
When it comes to coronavirus, we have flexible solutions for your testing needs. In response to the global outbreak of the novel coronavirus disease (COVID-19), Luminex has developed multiple solutions to enhance our offerings in order to automate and facilitate the detection of SARS-CoV-2. ARIES® S

These products are for Research Use Only. Not for use in diagnostic procedures. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.

  1. Luminex does not endorse any specific LDT. Performance characteristics of Laboratory Developed Tests are determined by the laboratory.

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 (RUO)

The NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 (NxTAG® RPP + SARS-CoV-2) is a qualitative test for the detection of nucleic acids from multiple respiratory viruses and bacteria in nasopharyngeal swabs, oropharyngeal swabs, nasal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, and nasal washes.

The NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 (RUO) was developed for use on the MAGPIX® NxTAG-enabled System, and offers:

  • Comprehensive Panel: Detects 20 viral pathogens, including SARS-CoV-2 (ORF1ab and M gene) and 3 bacterial pathogens, in a single well—enabling thorough respiratory health analysis.
  • Scalable Throughput: Process up to 96 samples in less than 3 hours post-extraction, accommodating variable, day-to-day testing demand.
  • Minimal Hands-on Time: Pre-plated, lyophilized reagents enable a simple workflow with just one pipetting step, ensuring an easy fit in any lab’s daily routine.

 

Viral Targets

Bacterial Targets

Influenza A Human Metapneumovirus Chlamydophila pneumoniae
Influenza A – subtype H1 Adenovirus Mycoplasma pneumoniae
Influenza A – subtype H3 Parainfluenza 1 Legionella pneumoniae
Influenza A – subtype 2009 H1N1 Parainfluenza 2  
Influenza B Parainfluenza 3  
SARS-CoV-2 Parainfluenza 4  
Coronavirus HKU1 Respiratory Syncytial Virus A  
Coronavirus N63L Respiratory Syncytial Virus B  
Coronavirus OC43 Rhinovirus/Enterovirus  
Coronavirus 229E Human Bocavirus  

Workflow

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 Workflow Step 1

Step 1

Add 1-96 extracted samples to pre-plated test wells.

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 Workflow Step 1

Step 2

Perform Integrated multiplex PCR and bead hybridization.

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2 Workflow Step 3

Step 3

Read on MAGPIX® Instrument.

NxTAG® CoV Extended Panel (RUO)

As a high throughput, targeted option, we have developed the NxTAG® CoV Extended Panel (RUO), which can detect SARS-CoV-2, as well as SARS-CoV and MERS-CoV.

The NxTAG® CoV Extended Panel (RUO) was developed for use on the MAGPIX® NxTAG-enabled System, and offers:

  • SARS-CoV-2, SARS-CoV, and MERS-CoV detection, enabling results.
  • A highly scalable, cost-effective assay that can process up to 96 samples in less than 3 hours post-extraction.
  • The flexibility to run tests in any combination—use the NxTAG CoV panel as a standalone test for coronavirus detection, detect 21 other common respiratory pathogens with the NxTAG® Respiratory Pathogen Panel (RPP), or run both tests in parallel for a complete picture of respiratory health.

Watch this video to see how to run the NxTAG® CoV Extended Panel:

These products are for Research Use Only. Not for use in diagnostic procedures. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.

Ordering Information:


ARIES® SARS-CoV-2 Assay

Product Registration Status Part Number
ARIES® SARS-CoV-2 Assay*
RUO 50-10048

NxTAG® CoV Extended Panel

Product Registration Status Part Number
NxTAG® CoV Extended Panel
RUO X054C0462

NxTAG® Respiratory Pathogen Panel + SARS-CoV-2

Product Registration Status Part Number
NxTAG® Respiratory Pathogen Panel + SARS-CoV-2
RUO X056C0470
MAGPIX®   MAGPIX-XPONENT
SYNCT™ Software   CN-SW47
* Protocol file provided separately
Assay and Protocol files available separately

These products are for Research Use Only. Not for use in diagnostic procedures. Please contact Luminex at [email protected] to obtain the appropriate product information for your country of residence.